aspirin has been researched along with Vasospasm, Intracranial in 7 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Vasospasm, Intracranial: Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aneurysmal subarachnoid hemorrhage patients treated at a single institution between November 2011 and December 2017 were divided according to whether they received aspirin monotherapy or DAPT after endovascular treatment." | 7.96 | Dual antiplatelet therapy does not improve outcomes after aneurysmal subarachnoid hemorrhage compared with aspirin monotherapy. ( Almandoz, JED; Contestabile, E; Kayan, Y; Milner, AA; Mulder, M; Scholz, JM; Stiernagle, K; Tipps, ME; Wallace, AN, 2020) |
| "Aspirin users were older on average than nonusers (59 years of age compared with 53 years; p = 0." | 5.32 | Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. ( Atkinson, JL; Friedman, JA; McClelland, RL; McIver, JI; Meyer, FB; Nichols, DA; Pichelmann, MA; Piepgras, DG; Toussaint, LG; Wijdicks, EF, 2004) |
| "Aneurysmal subarachnoid hemorrhage patients treated at a single institution between November 2011 and December 2017 were divided according to whether they received aspirin monotherapy or DAPT after endovascular treatment." | 3.96 | Dual antiplatelet therapy does not improve outcomes after aneurysmal subarachnoid hemorrhage compared with aspirin monotherapy. ( Almandoz, JED; Contestabile, E; Kayan, Y; Milner, AA; Mulder, M; Scholz, JM; Stiernagle, K; Tipps, ME; Wallace, AN, 2020) |
| "OBJECTIVE Clinical vasospasm and delayed cerebral ischemia (DCI) are devastating complications of aneurysmal subarachnoid hemorrhage (aSAH)." | 2.87 | Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia. ( Allan, L; Broderick, J; Brown, RD; Chalouhi, N; Chimowitz, M; Derdeyn, CP; Hasan, D; Jabbour, P; Leira, EC; Nagahama, Y; Nakagawa, D; Starke, RM; Torner, JC; Zanaty, M, 2018) |
| "Cerebral vasospasm was more often only mild and rates of cerebral infarctions were lower in the OTA group but not on a significant level." | 1.51 | Pain medication at ictus of subarachnoid hemorrhage-the influence of one-time acetylsalicylic acid usage on bleeding pattern, treatment course, and outcome: a matched pair analysis. ( Brawanski, N; Bruder, M; Kashefiolasl, S; Keil, F; Konczalla, J; Seifert, V; Won, SY, 2019) |
| "Aspirin pretreatment prevented the diffuse thrombosis of cortical and subcortical vessels after aSDH." | 1.48 | Direct visualization of microcirculation impairment after acute subdural hemorrhage in a novel animal model. ( Hsieh, ST; Huang, SJ; Lee, JE; Lin, WC; Po-Hao Huang, A; Tsai, JC; Wang, HC; Wang, KC, 2018) |
| "Unilateral vertebral artery dissection has been described in fewer than 40% of cases of RCVS." | 1.39 | Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section. ( Do, HM; Mitchell, LA; Santarelli, JG; Singh, IP, 2013) |
| "Aspirin users were older on average than nonusers (59 years of age compared with 53 years; p = 0." | 1.32 | Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. ( Atkinson, JL; Friedman, JA; McClelland, RL; McIver, JI; Meyer, FB; Nichols, DA; Pichelmann, MA; Piepgras, DG; Toussaint, LG; Wijdicks, EF, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Wallace, AN | 1 |
| Kayan, Y | 1 |
| Almandoz, JED | 1 |
| Mulder, M | 1 |
| Milner, AA | 1 |
| Scholz, JM | 1 |
| Stiernagle, K | 1 |
| Contestabile, E | 1 |
| Tipps, ME | 1 |
| Mansoor, T | 1 |
| Alsarah, AA | 1 |
| Mousavi, H | 1 |
| Khader Eliyas, J | 1 |
| Girotra, T | 1 |
| Hussein, O | 1 |
| Nagahama, Y | 1 |
| Allan, L | 1 |
| Nakagawa, D | 1 |
| Zanaty, M | 1 |
| Starke, RM | 1 |
| Chalouhi, N | 1 |
| Jabbour, P | 1 |
| Brown, RD | 1 |
| Derdeyn, CP | 1 |
| Leira, EC | 1 |
| Broderick, J | 1 |
| Chimowitz, M | 1 |
| Torner, JC | 1 |
| Hasan, D | 1 |
| Wang, HC | 1 |
| Tsai, JC | 1 |
| Lee, JE | 1 |
| Huang, SJ | 1 |
| Po-Hao Huang, A | 1 |
| Lin, WC | 1 |
| Hsieh, ST | 1 |
| Wang, KC | 1 |
| Bruder, M | 1 |
| Kashefiolasl, S | 1 |
| Keil, F | 1 |
| Brawanski, N | 1 |
| Won, SY | 1 |
| Seifert, V | 1 |
| Konczalla, J | 1 |
| Mitchell, LA | 1 |
| Santarelli, JG | 1 |
| Singh, IP | 1 |
| Do, HM | 1 |
| Toussaint, LG | 1 |
| Friedman, JA | 1 |
| Wijdicks, EF | 1 |
| Piepgras, DG | 1 |
| Pichelmann, MA | 1 |
| McIver, JI | 1 |
| McClelland, RL | 1 |
| Nichols, DA | 1 |
| Meyer, FB | 1 |
| Atkinson, JL | 1 |
1 trial available for aspirin and Vasospasm, Intracranial
| Article | Year |
|---|---|
Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
Topics: Adult; Aged; Aspirin; Brain Ischemia; Case-Control Studies; Clopidogrel; Embolization, Therapeutic; | 2018 |
6 other studies available for aspirin and Vasospasm, Intracranial
| Article | Year |
|---|---|
Dual antiplatelet therapy does not improve outcomes after aneurysmal subarachnoid hemorrhage compared with aspirin monotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Dual Anti-Platelet Therapy; Female; Humans; Mal | 2020 |
COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin.
Topics: Adult; Aspirin; Cerebral Arteries; COVID-19; Female; Humans; Nimodipine; Syndrome; Treatment Outcome | 2021 |
Direct visualization of microcirculation impairment after acute subdural hemorrhage in a novel animal model.
Topics: Acute Disease; Animals; Aspirin; Blood Gas Monitoring, Transcutaneous; Blood-Brain Barrier; Brain; D | 2018 |
Pain medication at ictus of subarachnoid hemorrhage-the influence of one-time acetylsalicylic acid usage on bleeding pattern, treatment course, and outcome: a matched pair analysis.
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebral Infarction; Female; Fibrinolytic Agents; Headache; Ho | 2019 |
Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section.
Topics: Aspirin; Cerebral Angiography; Cesarean Section; Clopidogrel; Female; Headache; Humans; Magnetic Res | 2013 |
Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Aspirin; Female; Humans; Incidence; Male; Medical Records; Middle Aged; Platelet Aggreg | 2004 |